Researchers at the University of Toronto and New York University Grossman School of Medicine developed an AI technology, ZFDesign, that can design zinc finger proteins to target any stretch of DNA in the human genome. The technology, which they say “levels the playing field for zinc fingers and CRISPR,” could opening a door to enable gene therapies for a broad range of health conditions.